We’ve compiled a useful collection of resources to learn more about Medrio and various aspects of managing your clinical trial in today’s complex and evolving environment.
As clinical trials grow in complexity, study managers need adaptive, unified RTSM technology to help reduce costs and maintain accurate, real-time study data.
Collecting participant data securely is a critical part of running any clinical trial, whether it is decentralized, in-clinic, or somewhere in between. Medrio EDC and ePRO solutions are important assets that help CROs and sponsors do more with less.
Sponsors can reduce the burden of adopting new hybrid decentralized trial technology by explaining its relevance and taking steps to reduce the cost of change.
Employing eConsent benefits participants, sites, sponsors and CROs. In this article, a Medrio Subject Matter Expert explains how this technology creates important advantages for all clinical trial stakeholders.
Why it is time to rethink the status quo around randomization and supply management in early phase studies?
Participant education is a critical part of informed consent and one that is easy to improve by leveraging established patient education best practices. Medrio CEO Nicole Latimer discusses some of the most successful approaches she has seen in her career:
Many early phase studies rely on manual methods of managing participant randomization and the study supply chain. But increasing complexities in both study design and global supply chain necessitate more flexible, responsive solutions for early …
ICFs can be extremely long and complex. Approaches that prioritize accessibility and promote participant comprehension are key to ensuring a smooth process that supports fully informed consent – eConsent meets those needs while being cost-effective and scalable.
Does your CRO or sponsor have a policy around IP numbering in clinical trials? If not, they could be putting your clinical trial at risk.
Smart IP Packaging Helps Clinical Trials Avoid Supply Chain Hurdles to Study Startup Ian Davison, Ph.D. Neuroscience, Medrio’s In-house RTSM Subject Matter Expert Packaging decisions may seem benign, but they can have a direct impact …
The Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy Medrio’s eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an …
In this episode, we discuss with Kafayat Babajide, Director of Patient Insights & Experience with Johnson and Johnson, the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process.
© Copyright 2023 Medrio, Inc. All rights reserved.
Sign up to have our the latest insights delivered to your inbox.